ArticlePediatric research2026
The shifting burden of early-onset inflammatory bowel disease: a global analysis.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly-onset inflammatory bowel disease (EO-IBD), affecting children under age 10 years, has an emerged as a distinct global pediatric health concern with increasing clinical and epidemiological features. Existing data, however, remain insufficient to characterize its full global burden or associated socioeconomic disparities.
methodsUsing Global Burden of Disease 2021 data, we analyzed EO-IBD incidence, mortality, prevalence, and disability-adjusted life years (DALYs) across 204 countries and territories from 1990 to 2021. Decomposition analysis, inequality metrics, and frontier benchmarking were applied to assess temporal trends, cross-national disparities, and burden shifts across levels of Socio-demographic index (SDI).
resultsBetween 1990 and 2021, global EO-IBD mortality declined by roughly 70%, while incidence remained relatively stable. Prevalence rose, reflecting a growing population of children living with the condition. High-SDI regions recorded the highest incidence but the lowest mortality. Inequality analyses pointed a shifting mortality burden toward lower-SDI populations, and frontier analysis revealed substantial health system performance disparities independent of socioeconomic status.
conclusionsThis comprehensive global assessment of EO-IBD in children reveals diverging mortality and incidence trends alongside persistent socioeconomic inequalities. The findings underscore the urgent need for equitable healthcare access and targeted preventive strategies worldwide, and improved monitoring of pediatric health system equity. IMPACT: Global mortality from early-onset inflammatory bowel disease (EO-IBD) declined by approximately 70% between 1990 and 2021. Despite substantial progress, marked socioeconomic inequalities in EO-IBD mortality persist across regions. This study provides the first comprehensive global assessment of EO-IBD mortality trends and disparities. The findings highlight the need for equitable pediatric IBD care and targeted prevention strategies in resource-limited settings.
Identifiers
42463801What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.